IHC Detection Kit Combines Sensitive Chemistry and Flexible Software

OptiView detection significantly enhances stain quality, allowing pathologists to view IHC assays more clearly than before.

Ventana Medical Systems, Inc. (Oro Valley, AZ, USA), a member of the Roche group (Basel, Switzerland), launched the OptiView DAB IHC detection kit, which is compatible with the entire line of Ventana Benchmark instruments.

Ventana solutions are used in clinical histology and drug development-research laboratories worldwide. The company's "Smart Systems" – intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals.

"OptiView detection is an important, innovative solution to help pathologists be confident that even with the most difficult-to-view markers, they are making the right diagnoses and driving the right patient treatments," said Greg Yap, head of advanced staining assays for Ventana.

Related Links:
Ventana Medical Systems, Inc.
Roche